Previous Article | Next Article ![]()
Infection and Immunity, January 2001, p. 237-244, Vol. 69, No. 1
Zoology Department, Faculty of Science, Cairo
University, Cairo,1 and Biomedical
Research Center for Infectious Diseases, The Egyptian Organization for
Biological Products and Vaccines,2 and
Department of Tropical Medicine, Theodore Bilharz Research
Institute,4 Giza, Egypt, and Department
of Tropical Public Health, Harvard School of Public Health, Boston,
Massachusetts3
Received 22 February 2000/Returned for modification 13 April
2000/Accepted 6 October 2000
Recently we reported that human T- and B-cell recognition of a
42-kDa protein (p42) in soluble extracts of adult Schistosoma mansoni worms correlates with resistance to reinfection with
S. mansoni or S. haematobium. Amino acid
microsequencing of p42 revealed that it consists predominantly of
schistosome glyceraldehyde 3-phosphate dehydrogenase
(SG3PDH). We have expressed SG3PDH in Escherichia coli and
purified the recombinant protein in a soluble and enzymatically active form. Recombinant SG3PDH (rSG3PDH) reacted with human
monospecific antibodies to p42. Lymphoproliferation and production of
interleukin-4 and gamma interferon (IFN-
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.237-244.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Human T- and B-Cell Responses to Schistosoma
mansoni Recombinant Glyceraldehyde 3-Phosphate Dehydrogenase
Correlate with Resistance to Reinfection with S. mansoni or Schistosoma haematobium
after Chemotherapy
) after in vitro stimulation
with rSG3PDH and serum isotype responses to rSG3PDH were examined in
individuals with extremes of resistance and susceptibility to
reinfection after treatment of previous S. mansoni or
S. haematobium infection. Lymphoproliferation and IFN-
production in response to rSG3PDH and the presence of serum
immunoglobulin G1 (IgG1), IgG3, and IgA antibodies to rSG3PDH
generally characterized individuals who are resistant to
reinfection after chemotherapy. The data indicate that T- and B-cell
immune reactivity to rSG3PDH correlates with resistance to reinfection,
confirming previous studies identifying SG3PDH as a target of
protective immunity in humans, and suggest that SG3PDH should be
investigated as a possible vaccine for human schistosomiasis.
*
Corresponding author. Mailing address: Zoology
Department, Faculty of Science, Cairo University, Cairo 12613, Egypt.
Phone: (202) 5676-708. Fax: (202) 3602-988. E-mail:Rashika{at}FRCU.EUN.Eg.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»